Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance - The U.S. E-37 Trial

Neuromodulation

Volumn 19, Issue 2, 2016, Pages 188-195

  Fisher, Robert S ^a   Afra, Pegah ^b   Macken, Micheal ^c   Minecan, Daniela N ^d   Bagic, Anto ^e   Benbadis, Selim R ^f   Helmers, Sandra L ^g   Sinha, Saurabh R ^h   Slater, Jeremy ⁱ   Treiman, David ^j   Begnaud, Jason ^k   Raman, Pradheep ^k   Najimipour, Bita ^k  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j BARROW NEUROLOGICAL INSTITUTE   (United States)

^k Cyberonics Inc   (Italy)

more..

Author keywords

AspireSR; ictal tachycardia; vagus nerve stimulation; VNS therapy system

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONVULSION; DEVICE SAFETY; DISEASE SEVERITY; DRUG RESISTANT EPILEPSY; DYSPHONIA; FEMALE; GRAND MAL EPILEPSY; HEART RATE; HUMAN; IMPLANTED VAGUS NERVE STIMULATOR; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OROPHARYNX PAIN; OUTPATIENT CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; TACHYCARDIA; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; UNITED STATES; VAGUS NERVE STIMULATION; YOUNG ADULT; CLINICAL TRIAL; COMPLICATION; DEVICES; FOCAL EPILEPSY; MULTICENTER STUDY; PROCEDURES;

ADULT; AGED; DRUG RESISTANT EPILEPSY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 84958947780     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12376     Document Type: Article

References (21)

1. Ramsay RE, et al., Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 627-636.
2. DeGiorgio CM, et al., Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000; 41: 1195-1200.
3. Ben-Menachem E, et al., Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 616-626.
4. Fisher RS, Handforth A., Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999; 53: 666-669.
5. Fisher RS, Eggleston KS, Wright CW., Vagus nerve stimulation magnet activation for seizures: a critical review. Acta Neurol Scand 2015; 131: 1-8.
6. Morris GL III., A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy Behav 2003; 4: 740-745.
7. Morris GL III, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C,. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; 81: 1453-1459.
8. Boon P., et al., Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol 2001; 18: 402-407.
9. Wang H., et al., Long-term effect of vagus nerve stimulation on interictal epileptiform discharges in refractory epilepsy. J Neurol Sci 2009; 284: 96-102.
10. Majkowska-Zwolińska B, Zwoliński P, Roszkowski M, Drabik K,. Long-term results of vagus nerve stimulation in children and adolescents with drug-resistant epilepsy. Childs Nerv Syst 2012; 28: 621-628.
11. Block A, Fisher RS., Can patients perform volitional motor acts at the start of a seizure? J Clin Neurophysiol 1999; 16: 141-145.
12. Blum DE, Eskola J, Bortz JJ, Fisher RS,. Patient awareness of seizures. Neurology 1996; 47: 260-264.
13. Eggleston KS, Olin BD, Fisher, RS., Ictal tachycardia: the head-heart connection. Seizure 2014; 23: 496-505.
14. Borghs S, de la Loge C, Cramer JA., Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures. Epilepsy Behav 2012; 23: 230-234.
15. Cramer JA, Baker, GA, Jacoby A., Development of a new seizure severity questionnaire: initial reliability and validity testing. Epilepsy Res 2002; 48: 187-197.
16. O'Donoghue MF, Duncan, JS, Sander, JW., The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 1996; 37: 563-571.
17. Helmers SL., et al., Application of a computational model of vagus nerve stimulation. Acta Neurol Scand 2012; 126: 336-343.
18. Morris GL III, Mueller WM., Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999; 53: 1731-1735.
19. Hampel KG, Vatter H, Elger CE, Surges R,. Cardiac-based vagus nerve stimulation reduced seizure duration in a patient with refractory epilepsy. Seizure 2015; 26: 81-85.
20. Oliveira GR, Gondim Fde A, Hogan RE, Rola FH,. Heart rate analysis differentiates dialeptic complex partial temporal lobe seizures from auras and non-epileptic seizures. Arq Neuropsiquiatr 2007; 65: 565-568.
21. Ryvlin P., et al., The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia 2014; 55: 893-900.